Maria Martinez Garcia, Manuel Valiente, Juan Manuel Sepúlveda, Estela Pineda, María Ángeles Vaz-Salgado, Gonzalo Lendinez-Sanchez, Gabriel Velilla, Manuel Mazariegos-Rubi, Izaskun Valduvieco, Maria Castro-Henriques, Laia Cano, Stephen Garrett Marcus. "Azeliragon, a RAGE inhibitor, plus temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Final results from a dose-finding phase in the CAN-201 NDG trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2015